Nathanael S. Gray
InvestorScientific Advisory Board - Oncology; Krishnan-Shah Family Professor of Chemical and Systems Biology, Stanford at Red Tree Venture
Stanford
About
Scientific advisory board member focused on oncology; Stanford professor whose research on kinase inhibitors and degraders has influenced numerous clinical-stage cancer therapeutics.
Colleagues at Red Tree Venture
Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Brian Stearns
Red Tree Venture Labs Chemistry at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture







